News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
American Diabetes Association Announces Retirement of Chief Scientific & Medical Officer, Dr. Richard Kahn
December 17, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ALEXANDRIA, VA--(Marketwire - December 16, 2008) - The American Diabetes Association announced today that Richard A. Kahn, PhD, its Chief Scientific and Medical Officer, will be retiring in June 2009.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoff Tracker
Schrödinger Downsizes by 7% in Savings Push
May 21, 2025
·
209 min read
·
BioSpace Editorial Staff
Podcast
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
May 21, 2025
·
2 min read
·
Heather McKenzie
Opinion
Evolving Market Pressures Force Biopharma Companies to Cut Assets Early
May 21, 2025
·
5 min read
·
Michael N. Abrams
Collaboration
CRISPR Expands Focus, Pays Up To $95M in Sirius’ siRNA Pact
May 20, 2025
·
2 min read
·
Tristan Manalac